ORIC Pharmaceuticals Inc (ORIC) Implied Volatility Current

Tracking ORIC implied volatility helps you identify when options premiums on ORIC Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. ORIC Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when ORIC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor ORIC Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ORIC, tracking metrics like ORIC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ORIC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations.

The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ORIC implied volatility sits today versus where it has been. Our scanner ranks ORIC Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in ORIC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether ORIC Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.